A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)

Hemophilia Center of Western Pennsylvania, Pittsburgh

UCN Hemophilia and Thrombosis Center, Shandon

St Joseph's Children's Hospital, Center for Bleeding and Clotting Disorders, Tampa

Hemophilia and Thrombosis Center at the University of Colorado Anschutz Medical Campus, Aurora

Orthopedic Institute for Children, Orthopedic Hemophilia Treatment Center, Los Angeles

UC Davis Hemophilia Treatment Center, Sacramento

University of Michigan, Pediatric Hematology and Oncology, Ann Arbor

Addenbrooke's Hospital, Hemophilia and Thrombophilia Center, Cambridge

Hammersmith Hospital, Clinical Research Facility, Centre for Translational and Experimental Medicine, London

Queen Elizabeth Hospital Birmingham. Adult Hemophilia Centre, West Midlands Adult Comprehensive Care Hemophilia Centre, London

Royal London Hospital, Barts and the London Hemophilia Center, London

St Thomas' Hospital, Centre for Hemophilia, Hemostasis and Thrombosis, London

University Hospital Southampton NHS Foundation Trust, Southampton